-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $104

Benzinga·02/26/2026 15:58:49
Listen to the news
Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $98 to $104.